Glabrene

June 02, 2025
I鈥檓 a natural product that has good and bad properties.
What molecule am I?
Image of Glabrene 3D Image of Glabrene

Glabrene is a natural isoflavonoid that consists of two benzopyran ring systems with methyl and hydroxyl substituents. In 1976, Takeshi Kinoshita, Tamotsu Saitoh, and Shoji Shibata at the University of Tokyo reported its (Glycyrrhiza glabra).

Licorice root, widely used in traditional Chinese medicine, has several bioactive components, including glabrene and the closely related isoflavonoid glabridin1. Studies in the early 2000s included the 2001 finding by Jacob Vaya and collaborators at the Migal-Galilee Technological Center (Kiryat Shmona, Israel) and Tel Aviv University that glabrene, more so than glabridin, exhibited a agonism. The authors reported 鈥淭he stimulatory effects of glabrene in vivo were tissue specific and similar to those of estradiol2.鈥�

Two years later, Snait Tamir and colleagues at Migal-Galilee and Tel-Hai Academic College (Upper Galilee, Israel) reported that glabrene and another licorice root component, isoliquiritigenin3, are , a key factor in melanin biosynthesis. This result was significant because excessive melanin pigmentation can cause skin disorders such as melasama, age spots, and actinic damage.

Two 2024 reports describe negative and positive effects of glabrene. Qiang Zhang and co-workers at Northwest A&F University (Yangling, China) found that glabrene impurities in glabridin, now a commercial drug used for skin lightening to combat hyperpigmentation disorders, can in patients鈥� skin. The researchers used a standard zebrafish toxicity test to determine that glabrene has a significant lethal effect at low doses. They assert that their results show that enhanced quality control methods should be developed for purifying licorice-derived products.

On the positive side, Guoduo Zhang, Shumei Wang, and colleagues at the College and Hospital of Traditional Chinese Medicine (Chongqing) reported that glabrene could be useful for (NSCLC). In experiments on laboratory animals, they found that glabrene suppressed tumor growth by reversing the pathological morphology of tumor tissue and attenuating cancer cell proliferation, migration, and invasion. The key mechanism was the suppression of fibroblast growth factor receptor 3, a protein in NSCLC cells.

For further reading, see the , which includes information on glabrene.

1. CAS Reg. No. 59870-68-7.
2. CAS Reg. No. 50-28-2.
3. CAS Reg. No. 961-29-5.

Glabrene hazard information

Hazard class*GHS code and hazard statement
Skin corrosion/irritation, category 2H315鈥擟auses skin irritationChemical Safety Warning
Serious eye damage/eye irritation, category 2AH319鈥擟auses serious eye irritationChemical Safety Warning
Specific target organ toxicity, single exposure, respiratory tract irritation, category 3H335鈥擬ay cause respiratory irritationChemical Safety Warning

*Globally Harmonized System (GHS) of Classification and Labeling of Chemicals. .

Molecules from the Journals

Semaglutide and tirzepatide are anti鈥搕ype 2 diabetes and weight loss medications. They are glucagon-like peptide-11 (GLP-1) agonists that consist of long, branched-chain amino acid sequences. The table below shows their history and characteristics.

SemaglutideTirzepatide

CAS Reg. No.

910463-68-2

2023788-19-2

Developing company

Novo Nordisk (Bagsv忙rd, Denmark)

Eli Lilly (Indianapolis)

Trade names (diabetes)

Ozempic, Rybelsus

Mounjaro

Trade names (weight loss)

Wegovy

Zepbound

FDA approval year (diabetes)

2017

2022

FDA approval year (weight loss)

2023

2023

Number of amino acids

31

39

Empirical formula

C187H291N45O59

C225H348N48O68

Last month, Louis J. Aronne at Weill Cornell Medicine (New York) and 10 collaborators at six institutions in the United States, Ireland, and the United Kingdom reported a . In a听 72-week randomized study of 751 nondiabetic obese patients, the least-squares mean percent weight change was 鈭�20.2% with tirzepatide and 鈭�13.7% with semaglutide. The waist circumference results were 鈭�18.4 cm and 鈭�13.0 cm, respectively. Adverse side effects were similarly mild to moderate in both study groups. The authors concluded that tirzepatide is the superior treatment for this patient category.

1. CAS Reg. No. 123475-27-4 (human GLP-1).

Molecules from the Journals

MOTW briefly describes noteworthy molecules that appeared in recent journal articles. See this week's edition.

This molecule was suggested by a reader. We present听almost all of the molecules suggested by our readers.听If you have a molecule you would like us to consider, please send us a message. And thank you for your interest in Molecule of the Week! 鈥擡d.


Glabrene听fast facts

CAS Reg. No.60008-03-9
SciFinder听name摆3,8鈥�-叠颈-2H-1-benzopyran]-5鈥�,7-diol, 2鈥�,2鈥�-dimethyl-
Empirical
formula
C20H18O4
Molar mass322.36 g/mol
AppearanceWhite to beige powder
Melting point200鈥�203 潞C
Water
solubility
Slight
Chemical Abstract Service - a division of ACS

, the most authoritative and comprehensive source for chemical information.

Molecule of the Week needs your suggestions!

If your favorite molecule is not in our听archive, please send us a message. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!

Stay Ahead of the Chemistry Curve

Learn how ACS can help you stay ahead in the world of chemistry.